Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2017 1
2018 2
2019 3
2020 3
2021 5
2022 5
2023 5
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials.
Fertitta L, Bergqvist C, Sarin KY, Plotkin SR, Moertel C, Petersen AK, Cannon A, Berman Y, Pichard DC, Röhl C, Lessing A, Brizion B, Peiffer B, Ravaud P, Tran VT, Armand ML, Moryousef S, Ferkal S, Jannic A, Ezzedine K, Wolkenstein P; Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) international collaboration. Fertitta L, et al. Br J Dermatol. 2024 Jan 23;190(2):216-225. doi: 10.1093/bjd/ljad397. Br J Dermatol. 2024. PMID: 37877514
Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1.
Rance G, Zanin J, Maier A, Chisari D, Haebich KM, North KN, Dabscheck G, Seal ML, Delatycki MB, Payne JM. Rance G, et al. Among authors: haebich km. JAMA Netw Open. 2021 Dec 1;4(12):e2136842. doi: 10.1001/jamanetworkopen.2021.36842. JAMA Netw Open. 2021. PMID: 34870681 Free PMC article.
Sensory Processing in Children and Adolescents with Neurofibromatosis Type 1.
Pride NA, Haebich KM, Walsh KS, Lami F, Rouel M, Maier A, Chisholm AK, Lorenzo J, Hearps SJC, North KN, Payne JM. Pride NA, et al. Among authors: haebich km. Cancers (Basel). 2023 Jul 14;15(14):3612. doi: 10.3390/cancers15143612. Cancers (Basel). 2023. PMID: 37509275 Free PMC article.
Sex- and age-related differences in autistic behaviours in children with neurofibromatosis type 1.
Chisholm AK, Lami F, Haebich KM, Ure A, Brignell A, Maloof T, Pride NA, Walsh KS, Maier A, Rouel M, Granader Y, Barton B, Darke H, Fuelscher I, Dabscheck G, Anderson VA, Williams K, North KN, Payne JM. Chisholm AK, et al. Among authors: haebich km. J Autism Dev Disord. 2023 Jul;53(7):2835-2850. doi: 10.1007/s10803-022-05571-6. Epub 2022 Apr 20. J Autism Dev Disord. 2023. PMID: 35445370
Delineating the autistic phenotype in children with neurofibromatosis type 1.
Chisholm AK, Haebich KM, Pride NA, Walsh KS, Lami F, Ure A, Maloof T, Brignell A, Rouel M, Granader Y, Maier A, Barton B, Darke H, Dabscheck G, Anderson VA, Williams K, North KN, Payne JM. Chisholm AK, et al. Among authors: haebich km. Mol Autism. 2022 Jan 4;13(1):3. doi: 10.1186/s13229-021-00481-3. Mol Autism. 2022. PMID: 34983638 Free PMC article.
Generation of four iPSC lines from Neurofibromatosis Type 1 patients.
Bozaoglu K, Shern Lee W, Haebich KM, North KN, Payne JM, Lockhart PJ. Bozaoglu K, et al. Among authors: haebich km. Stem Cell Res. 2020 Dec;49:102013. doi: 10.1016/j.scr.2020.102013. Epub 2020 Oct 1. Stem Cell Res. 2020. PMID: 33091851 Free article.
Cognition, ADHD Symptoms, and Functional Impairment in Children and Adolescents With Neurofibromatosis Type 1.
Payne JM, Haebich KM, MacKenzie R, Walsh KS, Hearps SJC, Coghill D, Barton B, Pride NA, Ullrich NJ, Tonsgard JH, Viskochil D, Schorry EK, Klesse L, Fisher MJ, Gutmann DH, Rosser T, Packer RJ, Korf B, Acosta MT, Bellgrove MA, North KN. Payne JM, et al. Among authors: haebich km. J Atten Disord. 2021 Jun;25(8):1177-1186. doi: 10.1177/1087054719894384. Epub 2019 Dec 14. J Atten Disord. 2021. PMID: 31838937
24 results